Clinical Trial Update: A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial of oprozomib with pomalidomide and dexamethasone in adults with primary refractory or relapsed and refractory multiple myeloma; study terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Oprozomib (oprozomib)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED | Results posted: 2021-04-27